Selected research
Market Structure
Global CRO in Clinical Trials Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global CRO in Clinical Trials market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for CRO in Clinical Trials is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for CRO in Clinical Trials is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for CRO in Clinical Trials is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for CRO in Clinical Trials is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of CRO in Clinical Trials include Labcorp, IQVIA, Parexel, Syneos Health, PRA Health Sciences, PPD, ICON, MedPace and Wuxi AppTec, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global CRO in Clinical Trials market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of CRO in Clinical Trials and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents CRO in Clinical Trials revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the CRO in Clinical Trials market size, projected growth trends, production technologies, key applications, and end-use industries.
CRO in Clinical Trials Segment by Company
Labcorp
IQVIA
Parexel
Syneos Health
PRA Health Sciences
PPD
ICON
MedPace
Wuxi AppTec
CRO in Clinical Trials Segment by Type
Phase I Trial
Phase II Trial
Phase III Trial
Phase IV Trial
CRO in Clinical Trials Segment by End User
Pharmaceutical
Bio-pharm
Others
CRO in Clinical Trials Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global CRO in Clinical Trials market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of CRO in Clinical Trials and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of CRO in Clinical Trials.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of CRO in Clinical Trials in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global CRO in Clinical Trials industry.
Chapter 3: Detailed analysis of CRO in Clinical Trials companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, CRO in Clinical Trialsrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Phase I Trial
- Phase II Trial
- Phase III Trial
- Phase IV Trial
Applications
- Pharmaceutical
- Bio-pharm
- Others
Companies covered
- Labcorp
- IQVIA
- Parexel
- Syneos Health
- PRA Health Sciences
- PPD
- ICON
- MedPace
- Wuxi AppTec
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global CRO in Clinical Trials Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Phase I Trial
- 1.2.3 Phase II Trial
- 1.2.4 Phase III Trial
- 1.2.5 Phase IV Trial
- 1.3 Market Analysis by Application
- 1.3.1 Global CRO in Clinical Trials Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Pharmaceutical
- 1.3.3 Bio-pharm
- 1.3.4 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global CRO in Clinical Trials Growth Trends by Region
- 1.5.1 Global CRO in Clinical Trials Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 CRO in Clinical Trials Market Size by Region (2021-2026)
- 1.5.3 CRO in Clinical Trials Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global CRO in Clinical Trials Market Dynamics
- 2.1 CRO in Clinical Trials Industry Trends
- 2.2 CRO in Clinical Trials Industry Drivers
- 2.3 CRO in Clinical Trials Industry Opportunities and Challenges
- 2.4 CRO in Clinical Trials Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global CRO in Clinical Trials Revenue by Company (2021-2026)
- 3.2 Global CRO in Clinical Trials Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global CRO in Clinical Trials Key Company Head office and Area Served
- 3.4 Global CRO in Clinical Trials Company, Product Type & Application
- 3.5 Global CRO in Clinical Trials Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global CRO in Clinical Trials Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 CRO in Clinical Trials Players Market Share by Revenue in 2025
- 3.6.3 2025 CRO in Clinical Trials Tier 1, Tier 2, and Tier 3
4 CRO in Clinical Trials Market by Type
- 4.1 Global CRO in Clinical Trials Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global CRO in Clinical Trials Market Size by Type (2021-2032)
- 4.3 Global CRO in Clinical Trials Market Size Share by Type (2021-2032)
5 CRO in Clinical Trials Market by Application
- 5.1 Global CRO in Clinical Trials Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global CRO in Clinical Trials Market Size by Application (2021-2032)
- 5.3 Global CRO in Clinical Trials Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Labcorp
- 6.1.1 Labcorp Company Information
- 6.1.2 Labcorp Business Overview
- 6.1.3 Labcorp CRO in Clinical Trials Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Labcorp CRO in Clinical Trials Product Portfolio
- 6.1.5 Labcorp Recent Developments
- 6.2 IQVIA
- 6.2.1 IQVIA Company Information
- 6.2.2 IQVIA Business Overview
- 6.2.3 IQVIA CRO in Clinical Trials Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 IQVIA CRO in Clinical Trials Product Portfolio
- 6.2.5 IQVIA Recent Developments
- 6.3 Parexel
- 6.3.1 Parexel Company Information
- 6.3.2 Parexel Business Overview
- 6.3.3 Parexel CRO in Clinical Trials Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Parexel CRO in Clinical Trials Product Portfolio
- 6.3.5 Parexel Recent Developments
- 6.4 Syneos Health
- 6.4.1 Syneos Health Company Information
- 6.4.2 Syneos Health Business Overview
- 6.4.3 Syneos Health CRO in Clinical Trials Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Syneos Health CRO in Clinical Trials Product Portfolio
- 6.4.5 Syneos Health Recent Developments
- 6.5 PRA Health Sciences
- 6.5.1 PRA Health Sciences Company Information
- 6.5.2 PRA Health Sciences Business Overview
- 6.5.3 PRA Health Sciences CRO in Clinical Trials Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 PRA Health Sciences CRO in Clinical Trials Product Portfolio
- 6.5.5 PRA Health Sciences Recent Developments
- 6.6 PPD
- 6.6.1 PPD Company Information
- 6.6.2 PPD Business Overview
- 6.6.3 PPD CRO in Clinical Trials Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 PPD CRO in Clinical Trials Product Portfolio
- 6.6.5 PPD Recent Developments
- 6.7 ICON
- 6.7.1 ICON Company Information
- 6.7.2 ICON Business Overview
- 6.7.3 ICON CRO in Clinical Trials Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 ICON CRO in Clinical Trials Product Portfolio
- 6.7.5 ICON Recent Developments
- 6.8 MedPace
- 6.8.1 MedPace Company Information
- 6.8.2 MedPace Business Overview
- 6.8.3 MedPace CRO in Clinical Trials Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 MedPace CRO in Clinical Trials Product Portfolio
- 6.8.5 MedPace Recent Developments
- 6.9 Wuxi AppTec
- 6.9.1 Wuxi AppTec Company Information
- 6.9.2 Wuxi AppTec Business Overview
- 6.9.3 Wuxi AppTec CRO in Clinical Trials Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Wuxi AppTec CRO in Clinical Trials Product Portfolio
- 6.9.5 Wuxi AppTec Recent Developments
7 North America
- 7.1 North America CRO in Clinical Trials Market Size (2021-2032)
- 7.2 North America CRO in Clinical Trials Market Size by Type
- 7.2.1 North America CRO in Clinical Trials Market Size by Type (2021-2026)
- 7.2.2 North America CRO in Clinical Trials Market Size by Type (2027-2032)
- 7.2.3 North America CRO in Clinical Trials Market Share by Type (2021-2032)
- 7.3 North America CRO in Clinical Trials Market Size by Application
- 7.3.1 North America CRO in Clinical Trials Market Size by Application (2021-2026)
- 7.3.2 North America CRO in Clinical Trials Market Size by Application (2027-2032)
- 7.3.3 North America CRO in Clinical Trials Market Share by Application (2021-2032)
- 7.4 North America CRO in Clinical Trials Market Size by Country
- 7.4.1 North America CRO in Clinical Trials Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America CRO in Clinical Trials Market Size by Country (2021-2026)
- 7.4.3 North America CRO in Clinical Trials Market Size by Country (2027-2032)
- 7.4.4 North America CRO in Clinical Trials Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe CRO in Clinical Trials Market Size (2021-2032)
- 8.2 Europe CRO in Clinical Trials Market Size by Type
- 8.2.1 Europe CRO in Clinical Trials Market Size by Type (2021-2026)
- 8.2.2 Europe CRO in Clinical Trials Market Size by Type (2027-2032)
- 8.2.3 Europe CRO in Clinical Trials Market Share by Type (2021-2032)
- 8.3 Europe CRO in Clinical Trials Market Size by Application
- 8.3.1 Europe CRO in Clinical Trials Market Size by Application (2021-2026)
- 8.3.2 Europe CRO in Clinical Trials Market Size by Application (2027-2032)
- 8.3.3 Europe CRO in Clinical Trials Market Share by Application (2021-2032)
- 8.4 Europe CRO in Clinical Trials Market Size by Country
- 8.4.1 Europe CRO in Clinical Trials Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe CRO in Clinical Trials Market Size by Country (2021-2026)
- 8.4.3 Europe CRO in Clinical Trials Market Size by Country (2027-2032)
- 8.4.4 Europe CRO in Clinical Trials Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China CRO in Clinical Trials Market Size (2021-2032)
- 9.2 China CRO in Clinical Trials Market Size by Type
- 9.2.1 China CRO in Clinical Trials Market Size by Type (2021-2026)
- 9.2.2 China CRO in Clinical Trials Market Size by Type (2027-2032)
- 9.2.3 China CRO in Clinical Trials Market Share by Type (2021-2032)
- 9.3 China CRO in Clinical Trials Market Size by Application
- 9.3.1 China CRO in Clinical Trials Market Size by Application (2021-2026)
- 9.3.2 China CRO in Clinical Trials Market Size by Application (2027-2032)
- 9.3.3 China CRO in Clinical Trials Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia CRO in Clinical Trials Market Size (2021-2032)
- 10.2 Asia CRO in Clinical Trials Market Size by Type
- 10.2.1 Asia CRO in Clinical Trials Market Size by Type (2021-2026)
- 10.2.2 Asia CRO in Clinical Trials Market Size by Type (2027-2032)
- 10.2.3 Asia CRO in Clinical Trials Market Share by Type (2021-2032)
- 10.3 Asia CRO in Clinical Trials Market Size by Application
- 10.3.1 Asia CRO in Clinical Trials Market Size by Application (2021-2026)
- 10.3.2 Asia CRO in Clinical Trials Market Size by Application (2027-2032)
- 10.3.3 Asia CRO in Clinical Trials Market Share by Application (2021-2032)
- 10.4 Asia CRO in Clinical Trials Market Size by Country
- 10.4.1 Asia CRO in Clinical Trials Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia CRO in Clinical Trials Market Size by Country (2021-2026)
- 10.4.3 Asia CRO in Clinical Trials Market Size by Country (2027-2032)
- 10.4.4 Asia CRO in Clinical Trials Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa CRO in Clinical Trials Market Size (2021-2032)
- 11.2 South America, Middle East & Africa CRO in Clinical Trials Market Size by Type
- 11.2.1 South America, Middle East & Africa CRO in Clinical Trials Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa CRO in Clinical Trials Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa CRO in Clinical Trials Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa CRO in Clinical Trials Market Size by Application
- 11.3.1 South America, Middle East & Africa CRO in Clinical Trials Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa CRO in Clinical Trials Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa CRO in Clinical Trials Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa CRO in Clinical Trials Market Size by Country
- 11.4.1 South America, Middle East & Africa CRO in Clinical Trials Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa CRO in Clinical Trials Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa CRO in Clinical Trials Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa CRO in Clinical Trials Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst